Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review | BMJ Paediatrics Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Topic collections
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Original research letter

Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review

Online download statistics by month:

Online download statistics by month: March 2021 to March 2024

	Abstract	Full	Pdf
Mar 2021	199	191	88
Apr 2021	44	43	19
May 2021	35	33	17
Jun 2021	28	28	6
Jul 2021	64	63	15
Aug 2021	41	41	20
Sep 2021	53	56	7
Oct 2021	81	83	22
Nov 2021	73	73	28
Dec 2021	51	47	3
Jan 2022	54	61	19
Feb 2022	32	40	12
Mar 2022	29	31	9
Apr 2022	34	35	12
May 2022	49	50	22
Jun 2022	51	54	18
Jul 2022	23	23	4
Aug 2022	23	21	8
Sep 2022	32	33	16
Oct 2022	26	28	7
Nov 2022	25	26	17
Dec 2022	26	28	3
Jan 2023	20	19	9
Feb 2023	50	51	10
Mar 2023	34	35	8
Apr 2023	15	16	4
May 2023	14	15	4
Jun 2023	23	23	1
Jul 2023	17	17	6
Aug 2023	9	10	5
Sep 2023	15	13	1
Oct 2023	29	30	3
Nov 2023	25	26	3
Dec 2023	16	16	5
Jan 2024	15	15	9
Feb 2024	39	39	4
Mar 2024	10	10	17
Total	1404	1423	461